OSN New York and OSN New York Retina

OSN New York and OSN New York Retina

Source: Kim Brazzell, MD, PhD
September 07, 2020
1 min watch
Save

VIDEO: Kala CMO updates Eysuvis dry eye treatment progress

Source: Kim Brazzell, MD, PhD
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In this Healio Video Perspective, Kim Brazzell, MD, PhD, chief medical officer for Kala Pharmaceuticals, gives an update on the progress of Eysuvis for the short-term treatment of dry eye disease, which the company expects to launch by the end of 2020.